GT Biopharma, Inc. (GTBP)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jan. 28, 2026 | CORRESP | Neutral/Informational | Moderate | GT Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1. They are seeking to have the registra… | Read Filing EDGAR |
| Jan. 27, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has notified GT Biopharma, Inc. that it will not review their registration statement filed on January 21, 2026. The letter emphasizes that the responsibility for the accur… | Read Filing EDGAR |
| Dec. 2, 2025 | CORRESP | Neutral/Informational | Moderate | GT Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1. They are seeking to have the registra… | Read Filing EDGAR |
| Jul. 1, 2025 | CORRESP | Neutral/Informational | Moderate | GT Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1. They are seeking to have the registra… | Read Filing EDGAR |
| Jun. 27, 2025 | CORRESP | Concern from SEC | Moderate | GT Biopharma, Inc. submitted a response to the SEC's comment letter regarding their Registration Statement on Form S-1, filed on June 11, 2025. The SEC requested more detailed dis… | Read Filing EDGAR |
| Jun. 20, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has conducted a limited review of GT Biopharma's registration statement on Form S-1 filed on June 11, 2025, and has issued a comment regarding the disclosure of Greenshoe … | Read Filing EDGAR |